HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-lasting pigmentation more than its intensity is a reliable indicator of skin sun resistance.

AbstractBACKGROUND:
The currently adopted method for predicting sun sensitivity is Fitzpatrick's classification which however is based on self-reported burning tendency and tanning ability.
OBJECTIVE:
Determination of the individual UV susceptibility based on non-subjective parameters.
METHOD:
Minimal erythema dose (MED), intensity and duration of pigmentation on days 5, 9 and 16 following 1 MED and the levels of the melanin marker pyrrole-2,3,5-tricarboxylic acid (PTCA) were analysed in non-red-haired subjects (50, aged 20-46 years).
RESULTS:
Phenotype groups or phototypes showed a good correlation with PTCA yields and the persistence of pigmentation on day 16, but not with MED values. MED values did not show a significant correlation with PTCA yields. On the other hand, high values on day 16 were exhibited only by subjects having PTCA values higher than 200 ng/mg.
CONCLUSIONS:
Measurement persistence of pigmentation on day 16 represents a non-invasive and easy-to-perform method to evaluate photoprotection in those individuals escaping straightforward classification based on phenotype or anamnesis.
AuthorsEnrico M Procaccini, Alessandra Napolitano, Lucia Panzella, Emilia Prizio, Giuseppe Monfrecola
JournalDermatology (Basel, Switzerland) (Dermatology) Vol. 215 Issue 3 Pg. 173-9 ( 2007) ISSN: 1421-9832 [Electronic] Switzerland
PMID17823511 (Publication Type: Journal Article)
CopyrightCopyright 2007 S. Karger AG, Basel.
Chemical References
  • Melanins
Topics
  • Adult
  • Dose-Response Relationship, Radiation
  • Erythema (etiology)
  • Female
  • Hair (chemistry)
  • Humans
  • Male
  • Melanins (analysis)
  • Middle Aged
  • Radiation Tolerance (physiology)
  • Skin (radiation effects)
  • Skin Pigmentation (physiology, radiation effects)
  • Spectrophotometry
  • Time Factors
  • Ultraviolet Rays (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: